Valuation: Conavi Medical Corp.

Market Cap 28.29M 20.38M 17.61M 16.54M 15.05M 1.95B 28.75M 194M 75.79M 976M 76.53M 74.87M 3.24B P/E 2024 *
-
P/E 2025 -1.88x
Enterprise Value 42.35M 30.52M 26.36M 24.77M 22.53M 2.92B 43.05M 290M 113M 1.46B 115M 112M 4.86B EV / Sales 2024 *
-
EV / Sales 2025 7.18x
Free-Float
66.52%
Yield 2024 *
-
Yield 2025 -
1 day+6.99%
1 week+59.59%
Current month+62.96%
1 month+40.58%
3 months+9.65%
6 months-27.74%
Current year-33.31%
1 week 0.11
Extreme 0.11
0.22
1 month 0.1
Extreme 0.1021
0.22
Current year 0.1
Extreme 0.1021
0.43
1 year 0.1
Extreme 0.1021
0.56
3 years 0
Extreme 0.0007
1
5 years 0
Extreme 0.0007
1
10 years 0
Extreme 0.0007
1
Change 5-day change 1-year change 3-year change Capi.($)
+6.99%+59.59% - - 20.38M
-1.28%-0.96%+20.30%+10.08% 218B
-0.71%-1.13%-4.02%-20.68% 142B
-1.68%+4.14%-17.85%+28.66% 139B
+0.27%+5.11%-49.76%+0.29% 75.11B
-1.04%+2.10%+17.05%+14.70% 52.8B
+0.69%-0.51%-16.49%-15.50% 50.66B
-0.51%+1.75%+24.61%+18.21% 41.95B
-0.32%+1.31%+41.37%+44.38% 40.49B
-0.14%+2.68%+0.40%+4.47% 33.28B
Average +0.23%+1.78%+1.73%+9.40% 88.17B
Weighted average by Cap. -0.82%+1.23%+0.51%+7.52%

Financials

2024 2025
Net sales 2.16M 1.56M 1.34M 1.26M 1.15M 149M 2.2M 14.81M 5.79M 74.57M 5.85M 5.72M 248M 9.12M 6.57M 5.68M 5.34M 4.85M 629M 9.27M 62.51M 24.44M 315M 24.68M 24.14M 1.05B
Net income -43.62M -31.43M -27.15M -25.51M -23.2M -3.01B -44.33M -299M -117M -1.5B -118M -115M -5B -20.52M -14.78M -12.77M -12M -10.91M -1.41B -20.85M -141M -54.97M -708M -55.51M -54.3M -2.35B
Net Debt 82.74M 59.62M 51.5M 48.39M 44.01M 5.7B 84.1M 567M 222M 2.86B 224M 219M 9.49B 14.06M 10.14M 8.75M 8.23M 7.48M 969M 14.3M 96.38M 37.69M 485M 38.05M 37.23M 1.61B
Logo Conavi Medical Corp.
Conavi Medical Corp. is a Canada-based medical device company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary interventions (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.
Employees
-
Date Price Change Volume
14/08/26 USD 0.1444 -1.47% 21,829
13/08/26 USD 0.1466 +4.45% 65,168
12/08/26 USD 0.1403 +6.35% 60,070
11/08/26 USD 0.1319 -1.19% 582
10/08/26 USD 0.1335 -3.32% 7,354

Annual profits - Rate of surprise